CompletedNCT03235154
Official study titleBridging Care to HCV Treatment Among Opiate Dependent Patients on Buprenorphine/Naloxone Maintenance Therapy: A Pilot Study of Treating HCV With Epclusa at a Psychiatrist-staffed Outpatient Addiction Clinic
This study has finished and is no longer accepting participants.
In SomervilleAddictionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Community Research Initiative of New England
CompletedNCT00699218
Official study titleA Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Bipolar Depression
This study has finished and is no longer accepting participants.
In DavisBipolarity, DepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- University of California, Davis
CompletedACTRN12622001057774
Official study titleA pilot study to assess the feasibility, acceptability, and impact of a CBT-based micro-intervention to address the potential effects of social networking site use on well-being.
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 16+
- Countries
- Australia
- Sponsor
- University of Adelaide
CompletedNCT06632782
Official study titleA Pilot Study to Assess the Impact of Breath Awareness Using Pyramid on Symptoms of Anxiety and Depression in People With T2DM
This study has finished and is no longer accepting participants.
In Kuwait CityDepression, AnxietyBehavioural studyAges 30–80
- Countries
- Kuwait
- Sponsor
- Dasman Diabetes Institute
CompletedNCT01262170
Official study titleA Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke
This study has finished and is no longer accepting participants.
In MartinsburgAddictionInterventional studyAges 23–72
- Countries
- United States
- Sponsor
- Rock Creek Pharmaceuticals, Inc.
CompletedACTRN12609000521224
Official study titleExamining the effectiveness, safety and tolerability of 12 weeks of treatment with low-dose quetiapine (100-400 mg/day) in anorexia nervosa patients aged between 15 and 44 years in improving participants' physical and psychological health status
This study has finished and is no longer accepting participants.
Location not clearly listedEating disordersInterventional studyAges 15–44
- Countries
- Sponsor
- Astra Zeneca Australia
CompletedACTRN12613000742774
Official study titleA pilot study to test recruitment methods, feasibility and study
procedures for a planned randomised controlled trial of the
MindBabyBody program: an antenatal mindfulness intervention to reduce depression, stress and anxiety
This study has finished and is no longer accepting participants.
In ParkvilleAnxiety, DepressionInterventional studyAges 18–50
- Countries
- Australia
- Sponsor
- Murdoch Childrens Research Institute
TerminatedEUCTR 2004-002482-20
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepression, AnxietyHistorical research record
- Countries
- United Kingdom
- Sponsor
- Newcastle upon Tyne Hospitals NHS Trust